Global Prenatal & Maternal Diagnostic Market Worth $10.5

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Sep 20, 2016 at 7:00 AM

Global Prenatal & Maternal Diagnostic Market Worth $10.5 Billion by 2021 According to New research

Dublin, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Prenatal & Maternal Diagnostic Market Analysis to 2021" report to their offering. The global prenatal, maternal and newborn screening diagnostic test market will be worth over $10.5 billion, up from $8 billion today

This market is subdivided into ultrasound, fetal MRI, maternal serum and noninvasive prenatal screening technologies and will see a five year compound annual growth rate of 4.1%. The new report, entitled GLOBAL PRENATAL AND MATERNAL DIAGNOSTIC MARKET ANALYSIS to 2021 indicates that the launch of noninvasive prenatal screening tests (NIPTs) in 2011 dramatically altered the market dynamic, and this sub-section of the market will see an 18% CAGR to 2021. This is at the expense of more invasive techniques as chorionic villus sampling (CVS) or amniocentesis. When human genome sequencing was successfully accomplished, experts in the healthcare industry expected that DNA sequencing would mainly focus on genetic diseases in adults. Instead, the impact of sequencing technology has been primarily on prenatal, newborn and preimplantation genetic diagnosis (PGD) tests (prior to in vitro fertilization). In a short span of four years, the different types of maternal serum screening tests and fetal ultrasound tests are getting gradually replaced by the new technology of non-invasive prenatal tests (NIPTs). In the past four years, hundreds and thousands of these new tests have been performed in screening cffDNA from maternal blood. According to the WHO, nearly 140 million babies are born every year, out of which 5 million die in the first month of life, mostly in developing countries. For example, in India, about 5% to 15% of sick newborns have a metabolic disorder. This emphasizes the need for newborn screening for preventing disability and death by early intervention, follow-up and counselling. Globally, the use of maternal serum marker screening and ultrasound imaging for the detection of chromosome aneuploidies and other birth defects constitute a routine part of prenatal care in the first and/or second trimesters. Yet, both of these techniques have the disadvantages of high false positive rates, varying from 2% to 7%. If the results of these tests show that a fetus is at increased risk of aneuploidy, invasive approaches such as chorionic villus sampling (CVS) or amniocentesis are recommended for diagnosis. Key Topics Covered: 1.0 Introduction 2.0 Prenatal Pregnancy Complications: An Overview 3.0 Types of Genetic Diseases in Fetuses: An Overview 4.0 Genetic Counseling: An Overview 5.0 Prenatal Screening for Genetic Diseases: An Overview 6.0 Newborn Screening 7.0 Preconception/Carrier Screening 8.0 Pregnancy, Prenatal, Newborn and PGD-Related Technologies: An Overview 9.0 Market Analysis 10.0 Other Genetic Testing-Related Markets 11.0 Market SWOT and Strategy Analysis 12.0 Company Profiles - 23andMe Inc. - Abbott Laboratories - Abbott Molecular Inc. - Abcam plc - AB Sciex LLC - Adaltis S.r.l - Adaptive Biotechnologies Corp. - Affymetrix Inc. - Agena Biosciences Inc. - Agilent Technologies Inc. - Ambry Genetics Corp. - Analogic Corp. - Ariosa Diagnostics Inc. - Ansh Labs - Appistry Inc. - ARUP Laboratories - AssureRx Health Inc. - Asuragen Inc. - Athena Diagnostics Inc. - AutoGenomics Inc. - Base4 Innovation Ltd. - Beckman Coulter Inc. - Berry Genomics Co., Ltd. - Bina Technologies Inc. - Bio-Rad (Israel) Laboratories Inc. - BGI - Blueprint Genetics Oy - Boreal Genomics Inc. - Cambridge Epigenetix Ltd. - Claris Lifesciences - CeGaT GmbH - Centogene AG - Chromosystems Instruments & Chemicals GmbH - Chronix Biomedical Inc. - Claritas Genomics Inc. - CLC bio A/S - Combimatrix Corp. - Contec Medical Systems Co., Ltd. - Coriell Life Sciences Inc. - Correlagen Diagnostics Inc. - Counsyl Inc. - Courtagen Life Sciences Inc. - Creative Diagnostics - Cynvenio Biosystems Inc. - Diagnostic Automation/Cortex Diagnostics Inc. - Demeditec Diagnostics GmbH - DRG International Inc. - DNA Electronics Ltd. - DNA Link Inc. - DNAnexus Inc. - Eagle Biosciences Inc. - Eagle Genomics Ltd. - Enzymatics Inc. - Esoate SpA - Eurofins MWG Operon Inc. - Exiqon A/S - Fakuda Denshi Co, Ltd. - GATC Biotech AG - GE Healthcare Ltd. - GenapSys Inc. - Gene by Gene Ltd. - Genection Inc. - GeneDx Inc. - GenePeeks Inc. - Genesis Genetics - Genetadi Biotech S.L. - Genoma Group Srl - Genomed AG - GenPath Diagnostics - Genway Biotech Inc. - Good Start Genetics Inc. - Hitachi Medical Systems America Inc. - Hologic Inc. - Illumina Inc. - INEX Innovations Exchange Pte., Ltd. - Invitae Corp. - Laboratory Corporation of America Inc. - LifeCodexx AG - Monobind Inc. - Multiplicom NV - Myriad Genetics - Natera Inc. - Natus Medical Inc. - NewGene Ltd. - NIPD Genetics Ltd. - Oxford Gene Technology - Parabase Genomics Inc. - Pathway Genomics Corp. - PerkinElmer Life and Analytical Sciences Inc. - Premaitha Health PLC - Progenity Inc. - Qiagen N.V. - Quest Diagnostics Inc. - Ravgen Inc. - Recombine Inc. - Reproductive Genetics Institute Inc. - Reprogenetics Laboratories - Sebia Inc. - Sequenom Inc. - SeraCare Life Sciences Inc. - Siemens Healthcare - Sophia Genetics SA - SpOtOn Clinical Diagnostics Ltd. - Stra Biotech GmbH - Sygnis AG - SynapDx Corp. - Thermo Fisher Scientific Inc. - Transgenomic Inc. - Trivitron Healthcare Private Ltd. - Trovagene Inc. - Tute Genomics Inc. - Warp Drive Bio LLC - ZS Genetics Inc. - Zymo Research Corporation For more information about this report visit http://www.researchandmarkets.com/research/9h...l_prenatal Related Topics: Diagnostics , Women's Health

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

ecozy's Brezzano Switch: Brewing Simplicity at Home

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Aurora Innovation Faces Legal Heat Amid Delays

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Adding Fireplaces: Home Comfort or Construction Headache?

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

FuelCell Faces Class Action Crunch as Deadline Looms

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Johnson & Johnson Unveils Promising PsA Treatment Data

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...